HYBRID EVENT: You can participate in person at London, UK from your home or work.

2nd Edition of International Conference on Gastroenterology

September 24-26, 2026, London,UK

September 24 -26, 2026 | London, UK

Hepatic Fibrosis

Hepatic Fibrosis

Hepatic fibrosis is a condition characterized by the presence of scar tissue in the liver. It is the result of chronic inflammation caused by a variety of factors, including viral infections, alcohol consumption, and certain medications. Fibrosis is associated with a number of diseases, such as cirrhosis, liver cancer, and portal hypertension. The development of hepatic fibrosis is a complex process involving multiple cellular and molecular events. Initially, there is an infiltration of inflammatory cells into the liver. This triggers an inflammatory response, leading to the production of pro-inflammatory cytokines. These cytokines then activate the production of extracellular matrix molecules by hepatic stellate cells. As the extracellular matrix accumulates, it forms fibrous scar tissue, which can eventually lead to cirrhosis. In addition to the inflammatory process, other factors play a role in the development of hepatic fibrosis. Oxidative stress, which is an imbalance between free radicals and antioxidants, has been linked to liver fibrosis. In addition, elevated levels of cytokines and growth factors, as well as genetic factors, may also be involved.

Submit your abstract Today

Watsapp